| Tumor Targeted Albumin Coated Bismuth Sulfide Nanoparticles (Bi2S3) as Radiosensitizers and Carriers of Curcumin for Enhanced Chemoradiation Therapy H Nosrati, J Charmi, M Salehiabar, F Abhari, H Danafar ACS Biomaterials Science & Engineering 5 (9), 4416-4424, 2019 | 57 | 2019 |
| Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles H Nosrati, E Attari, F Abhari, M Barsbay, M Ghaffarlou, N Mousazadeh, ... Bioactive materials 7, 74-84, 2022 | 51 | 2022 |
| Folic acid modified bismuth sulfide and gold heterodimers for enhancing radiosensitization of mice tumors to X-ray radiation F Abhari, J Charmi, H Rezaeejam, Z Karimimoghaddam, H Nosrati, ... ACS sustainable chemistry & engineering 8 (13), 5260-5269, 2020 | 44 | 2020 |
| Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer H Nosrati, M Ghaffarlou, M Salehiabar, N Mousazadeh, F Abhari, ... Biomaterials advances 140, 213090, 2022 | 36 | 2022 |
| Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy M Salehiabar, M Ghaffarlou, A Mohammadi, N Mousazadeh, H Rahimi, ... Journal of Controlled Release 353, 850-863, 2023 | 29 | 2023 |
| Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model H Nosrati, Y Baghdadchi, R Abbasi, M Barsbay, M Ghaffarlou, F Abhari, ... Journal of Materials Chemistry B 9 (22), 4510-4522, 2021 | 27 | 2021 |
| Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery H Nosrati, F Abhari, J Charmi, S Davaran, H Danafar Bioorganic Chemistry 88, 102959, 2019 | 24 | 2019 |
| Improved synergic therapeutic effects of chemoradiation therapy with the aid of a co-drug-loaded nano-radiosensitizer under conventional-dose X-ray irradiation H Nosrati, J Charmi, F Abhari, E Attari, S Bochani, B Johari, H Rezaeejam, ... Biomaterials science 8 (15), 4275-4286, 2020 | 22 | 2020 |
| Preparation and evaluation of bismuth sulfide and magnetite‐based theranostic nanohybrid as drug carrier and dual MRI/CT contrast agent H Nosrati, M Salehiabar, F Mozafari, J Charmi, N Erdoğan, M Ghaffarlou, ... Applied Organometallic Chemistry 36 (11), e6861, 2022 | 20 | 2022 |
| Facile green synthesis of bismuth sulfide radiosensitizer via biomineralization of albumin natural molecule for chemoradiation therapy aim H Nosrati, F Abhari, J Charmi, M Rahmati, B Johari, S Azizi, H Rezaeejam, ... Artificial Cells, Nanomedicine, and Biotechnology 47 (1), 3832-3838, 2019 | 10 | 2019 |
| The impact of bismuth/gold core/shell nanoparticles in efficiency of breast cancer in Balb/C mouse radiation therapy F Abhari Tabriz University of Medical Sciences, Faculty of Medicine, 2020 | | 2020 |
